Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II trial of local human dental pulp mesenchymal stem cell injection for chronic periodontitis
ChiCTR2300073144Phase 2Not yet recruiting
- Sponsor
- Peking University Third Hospital
- Start
- Jul 2023
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of human dental pulp mesenchymal stem cells in chronic periodontitis (4 arms), sponsored by Peking University Third Hospital. Primary endpoints: Periodontal bone defect height and Incidence of treatment-emergent adverse events. Planned start Jul 2023; status: not yet recruiting.
02
Drugs
human dental pulp mesenchymal stem cells
03
Conditions
chronic periodontitis
Beyond the preview
Go deeper on ChiCTR2300073144.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300073144.